Markets › United States › NAS › OBIO

Orchestra BioMed Holdings Inc

NAS:OBIOHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$5.58+2.01%LiveIn session · ≈ AED 20.49 · Market cap $335.39M · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	97.5%	125.4%	90.9%	93.3%	92.3%	99.4%	—	—
Operating margin	−328.8%	2,787.6%	−924.3%	−1,866.2%	−2,437.5%	−154.7%	−154.7%	+0.0 pts
Net margin	−374.5%	2,943.0%	−951.3%	−1,779.7%	−2,313.3%	−157.4%	−157.4%	+0.0 pts
EBITDA margin	−326.4%	2,801.3%	−945.0%	−1,769.3%	−2,301.6%	−153.0%	—	—
Return on equity	44.0%	32.3%	−64.0%	−72.2%	−185.2%	−83.2%	−83.2%	+0.0 pts
Return on assets	−56.1%	−170.1%	−35.2%	−51.6%	−80.1%	−45.9%	−45.9%	+0.0 pts
Return on capital employed	−79.0%	−1,693.8%	−42.4%	−61.3%	−107.2%	−52.8%	—	—
Debt / equity	−0.2×	−0.1×	0.2×	0.0×	0.5×	0.3×	0.3×	+0.0%
Debt / assets	24.8%	41.9%	12.4%	1.8%	21.7%	13.9%	—	—
Interest coverage	0.0×	−23.5×	0.0×	0.0×	0.0×	−45.1×	—	—
Current ratio	2.5×	0.9×	4.6×	8.0×	4.3×	6.4×	6.4×	+0.0%
Quick ratio	2.5×	0.9×	4.5×	7.9×	4.3×	6.4×	—	—
Cash ratio	1.4×	0.8×	1.1×	2.7×	1.4×	2.1×	2.1×	+0.0%
Asset turnover	0.1×	−0.1×	0.0×	0.0×	0.0×	0.3×	—	—
Inventory turnover	2.1×	2.9×	1.2×	1.3×	1.2×	0.6×	—	—
Receivables turnover	33.9×	−6.5×	36.8×	27.9×	28.7×	352.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—